{
  "created_at": "Fri Jun 04 7:1:5 +0000 2021",
  "id_str": "1400678755685834753",
  "full_text": "A drug from AstraZeneca reduced the combined risk of death and recurrence in early-stage breast-cancer patients, a study found. The pill targets the genetic traits of tumors. https://t.co/8KAgoYWD04",
  "display_text_range": [
    0,
    198
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/8KAgoYWD04",
        "expanded_url": "https://on.wsj.com/3ieTmFM",
        "display_url": "on.wsj.com/3ieTmFM",
        "indices": [
          175,
          198
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 39,
  "favorite_count": 158,
  "possibly_sensitive": false,
  "original_created_at": "Fri Jun 04 05:00:13 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "アストラゼネカ社の薬が、早期乳がん患者の死亡と再発のリスクを合わせて減少させたことが明らかになった。この薬は、腫瘍の遺伝子形質をターゲットにしている。https://t.co/8KAgoYWD04"
    },
    {
      "locale": "zh",
      "full_text": "一项研究发现，阿斯利康的一种药物降低了早期乳腺癌患者的死亡和复发的综合风险。该药丸针对肿瘤的遗传特征。https://t.co/8KAgoYWD04"
    },
    {
      "locale": "zh-Hant",
      "full_text": "一項研究發現，阿斯利康的一種藥物降低了早期乳腺癌患者的死亡和復發的綜合風險。該藥丸針對腫瘤的遺傳特徵。https://t.co/8KAgoYWD04"
    }
  ]
}